Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
UCSF - ethambutol: TB and MAC
Product / population
Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal method
CrCl in mL/min where specified; no equation inferred.
Source revision
Page identifies TB institutional practice as of May 2025 and dialysis information as of May 2023.
Retrieved
2026-09-05
Local review status
Locally included source-specific summary. Regimen differences are not automatically resolved.
UCSF Infectious Diseases Management Program · Adults; source-specific institutional guidance. Match route, indication and renal replacement modality.
Renal method: CrCl in mL/min where specified; no equation inferred. Source date: Page identifies TB institutional practice as of May 2025 and dialysis information as of May 2023. Retrieved: 2026-09-05
Locally included source-specific summary. Regimen differences are not automatically resolved.
Dosing / renal protocol and limits
For tuberculosis at CrCl >30 mL/min, 20-24 mg/kg orally daily; below 30, the same dose three times weekly. The source limits the usual starting dose to 1600 mg and recommends ID input above 80 kg. MAC: 15 mg/kg daily when CrCl >30, or three times weekly below 30. Exactly 30 is not assigned by the displayed bands.
Intermittent HD: give the TB dose of 20-24 mg/kg initially and after HD; for MAC, 15 mg/kg initially and after HD. Continuous HD: TB 15-20 mg/kg daily; MAC 15 mg/kg daily. Consider therapeutic drug monitoring.
Use adjusted body weight with BMI >30 kg/m2; otherwise actual weight. These are combination-treatment regimens.
RDM30-030-ethambutol-1 · Source locator: UCSF - ethambutol: TB and MAC; renal/dosing sections and stated qualifiers
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.